6.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.80
Aprire:
$6.79
Volume 24 ore:
111.62K
Relative Volume:
0.32
Capitalizzazione di mercato:
$348.90M
Reddito:
-
Utile/perdita netta:
$-19.90M
Rapporto P/E:
-12.75
EPS:
-0.53
Flusso di cassa netto:
$-19.80M
1 W Prestazione:
-0.26%
1M Prestazione:
-4.21%
6M Prestazione:
+60.11%
1 anno Prestazione:
+52.88%
Diamedica Therapeutics Inc Stock (DMAC) Company Profile
Nome
Diamedica Therapeutics Inc
Settore
Industria
Telefono
(763) 496-5454
Indirizzo
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Confronta DMAC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
DMAC
Diamedica Therapeutics Inc
|
6.75 | 351.48M | 0 | -19.90M | -19.80M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.16 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.15 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.92 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.09 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.56 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-30 | Iniziato | TD Cowen | Buy |
| 2024-10-07 | Iniziato | H.C. Wainwright | Buy |
| 2024-04-24 | Ripresa | Craig Hallum | Buy |
| 2023-06-22 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-04-09 | Iniziato | Oppenheimer | Outperform |
| 2021-02-17 | Iniziato | ROTH Capital | Buy |
| 2020-10-30 | Iniziato | Guggenheim | Buy |
| 2020-07-08 | Iniziato | Maxim Group | Buy |
| 2019-04-30 | Iniziato | Dougherty & Company | Buy |
| 2019-03-05 | Iniziato | Lake Street | Buy |
Mostra tutto
Diamedica Therapeutics Inc Borsa (DMAC) Ultime notizie
Why Wall Street Experts Believe This Biotech Stock Represents a Major Opportunity - Barchart.com
Will DiaMedica Therapeutics Inc. stock reach Wall Street targetsWeekly Market Outlook & Free Real-Time Volume Trigger Notifications - newser.com
Order flow analysis tools used on DiaMedica Therapeutics Inc.July 2025 Final Week & Reliable Volume Spike Trade Alerts - newser.com
Why DiaMedica Therapeutics Inc. stock remains on watchlistsMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Will DiaMedica Therapeutics Inc. stock attract ESG investorsInsider Buying & AI Enhanced Trade Execution Alerts - newser.com
Is DiaMedica Therapeutics Inc. stock supported by innovation pipeline2025 Macro Impact & AI Powered Market Trend Analysis - newser.com
Visual analytics tools that track DiaMedica Therapeutics Inc. performanceJuly 2025 Market Mood & Real-Time Buy Signal Notifications - newser.com
Will breakout in DiaMedica Therapeutics Inc. lead to full recoveryJuly 2025 Levels & Low Drawdown Momentum Ideas - newser.com
Is DiaMedica Therapeutics Inc. still worth holding after the dipMarket Activity Summary & Community Consensus Stock Picks - newser.com
What momentum shifts mean for DiaMedica Therapeutics Inc.2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com
How DiaMedica Therapeutics Inc. stock performs in stagflationJuly 2025 Trends & Safe Investment Capital Preservation Plans - newser.com
Has DiaMedica Therapeutics Inc. formed a bullish divergenceMarket Activity Recap & Precise Swing Trade Entry Alerts - newser.com
Will DiaMedica Therapeutics Inc. stock outperform tech sector in 20252025 Dividend Review & Safe Capital Investment Plans - newser.com
How institutional buying supports DiaMedica Therapeutics Inc. stock2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com
Developing predictive dashboards with DiaMedica Therapeutics Inc. dataEarnings Miss & Safe Swing Trade Setups - newser.com
Short interest data insights for DiaMedica Therapeutics Inc.Weekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Can DiaMedica Therapeutics Inc. stock hit analyst price targetsQuarterly Trade Report & AI Driven Stock Movement Reports - newser.com
Using economic indicators to assess DiaMedica Therapeutics Inc. potentialPortfolio Profit Report & Weekly Stock Performance Updates - newser.com
Is DiaMedica Therapeutics Inc. stock cheap at current valuation2025 Year in Review & Fast Moving Stock Trade Plans - newser.com
Backtesting results for DiaMedica Therapeutics Inc. trading strategiesJuly 2025 Reactions & Free Reliable Trade Execution Plans - newser.com
Smart tools for monitoring DiaMedica Therapeutics Inc.’s price actionCEO Change & Weekly Market Pulse Updates - newser.com
Can DiaMedica Therapeutics Inc. stock double in next 5 years2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com
Can DiaMedica Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-11-01 02:03:37 - newser.com
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
DiaMedica Therapeutics (NASDAQ:DMAC) Coverage Initiated at TD Cowen - MarketBeat
Sector ETF performance correlation with DiaMedica Therapeutics Inc.Trade Risk Summary & Risk Controlled Stock Pick Alerts - newser.com
Published on: 2025-10-31 05:34:37 - newser.com
Live market analysis of DiaMedica Therapeutics Inc.Quarterly Trade Summary & Risk Managed Investment Signals - newser.com
What valuation multiples suggest for DiaMedica Therapeutics Inc. stockJuly 2025 Drop Watch & Low Drawdown Trading Techniques - newser.com
Diamedica Therapeutics Inc Azioni (DMAC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Diamedica Therapeutics Inc Azioni (DMAC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| STAHLBERG JAN | 10% Owner |
Aug 13 '25 |
Buy |
5.91 |
293,601 |
1,734,918 |
7,058,066 |
| STAHLBERG JAN | 10% Owner |
Aug 14 '25 |
Buy |
5.99 |
70,414 |
421,921 |
7,128,480 |
| STAHLBERG JAN | 10% Owner |
Aug 20 '25 |
Buy |
5.86 |
71,107 |
416,495 |
7,207,820 |
| STAHLBERG JAN | 10% Owner |
Aug 26 '25 |
Buy |
6.00 |
59,648 |
357,888 |
7,713,693 |
| STAHLBERG JAN | 10% Owner |
Aug 22 '25 |
Buy |
5.96 |
59,788 |
356,576 |
7,315,780 |
| STAHLBERG JAN | 10% Owner |
Aug 27 '25 |
Buy |
6.00 |
50,772 |
304,632 |
7,764,465 |
| STAHLBERG JAN | 10% Owner |
Aug 21 '25 |
Buy |
5.96 |
48,172 |
287,028 |
7,255,992 |
| STAHLBERG JAN | 10% Owner |
Aug 15 '25 |
Buy |
6.00 |
8,233 |
49,398 |
7,136,713 |
| STAHLBERG JAN | 10% Owner |
Jul 23 '25 |
Buy |
3.50 |
1,542,857 |
5,400,000 |
6,764,465 |
| Von Koch Thomas | 10% Owner |
Jul 23 '25 |
Buy |
3.50 |
2,857,142 |
9,999,997 |
8,383,577 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):